IR · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $7.65B | $7.24B | $6.88B | $5.92B | $5.15B | $3.97B | $2.02B | $2.69B |
| Cost of Revenue | $4.31B | $4.07B | $3.99B | $3.59B | $3.16B | $2.57B | $1.24B | $1.68B |
| Gross Profit | $3.34B | $3.17B | $2.88B | $2.33B | $1.99B | $1.40B | $778.30M | $1.01B |
| Research & Development | $114.30M | $116.60M | $108.20M | $91.30M | $74.00M | $58.00M | $22.00M | $24.00M |
| Selling, General & Administrative | $1.44B | $1.34B | $1.27B | $1.10B | $1.03B | $789.30M | $409.60M | $434.60M |
| Operating Income | $1.14B | $1.30B | $1.16B | $817.30M | $565.70M | $59.60M | $194.10M | $443.00M |
| Interest Expense | — | — | $156.70M | $103.20M | $87.70M | $111.10M | $88.40M | $99.60M |
| Other Income / (Expense) | $44.60M | $48.90M | $37.00M | $29.20M | $44.00M | $8.10M | $4.70M | $7.20M |
| Income Before Taxes | $935.30M | $1.13B | $1.03B | $742.20M | $513.00M | -$45.40M | $110.20M | $349.50M |
| Provision for Income Taxes | $219.40M | $262.50M | $240.00M | $149.60M | -$21.80M | $11.40M | $12.90M | $80.10M |
| Net Income | $581.40M | $838.60M | $778.70M | $604.70M | $562.50M | -$33.30M | $159.10M | $269.40M |
| Basic EPS | $1.46 | $2.08 | $1.92 | $1.49 | $1.36 | -$0.09 | $0.78 | $1.34 |
| Diluted EPS | $1.45 | $2.06 | $1.90 | $1.47 | $1.34 | -$0.09 | $0.76 | $1.29 |
| Basic Shares Outstanding | 398.10M | 403.40M | 404.80M | 405.30M | 414.80M | 382.80M | 203.50M | 201.60M |
| Diluted Shares Outstanding | 401.00M | 407.20M | 409.00M | 410.20M | 421.20M | 382.80M | 208.90M | 209.10M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $3.37 | $3.34 | $3.41 | 5 | ↑0 ↓0 |
| Dec 2027 | $3.67 | $3.61 | $3.75 | 5 | ↑1 ↓1 |
| Dec 2028 | $3.99 | $3.85 | $4.09 | 3 | ↑0 ↓0 |
| Dec 2029 | $4.44 | $4.44 | $4.44 | 1 | ↑0 ↓0 |